Stay updated with breaking news from Biosimilar Technical Development Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On July 20, 2023, Sandoz announced that it plans to invest approximately $90 million to build a Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026. The facility will...
Deal Overview On July 18, 2023, Novartis AG (NYSE: NVS, $105.01, Market Capitalization $239.2 billion), a leading global medicine company, announced that its Board of ...